M3258 Size:Contact [email protected] for quotation ClH/c27-16-18-4-6-23-22(13-18)19(17-29-23)3-1-2-8-30-9-11-31(12-10-30)21-5-7-24-20(14-21)15-25(33-24)26(28)32

ClH/c27-16-18-4-6-23-22(13-18)19(17-29-23)3-1-2-8-30-9-11-31(12-10-30)21-5-7-24-20(14-21)15-25(33-24)26(28)32

Ketanserin depresses and in certain experiments reverses the vasoconstrictor response to 5-hydroxytryptamine in the perfused guinea-pig stomach

Docetaxel displays potent and broad antineoplastic properties

343(2):239-48

InChi: InChI=1S/C17H23N3O

M3258 Size:Contact [email protected] for quotation ClH/c27-16-18-4-6-23-22(13-18)19(17-29-23)3-1-2-8-30-9-11-31(12-10-30)21-5-7-24-20(14-21)15-25(33-24)26(28)32M3258 is an orally bioavailable, potent, reversible and highly selective immunoproteasome subunit LMP7 (5i) inhibitor. M3258 exerts high biochemical (IC50=3. 6 nM) and cellular (IC50=3. 4 nM) potency against the LMP7 subunit. M3258 shows strong antitumor efficacy in multiple myeloma xenograft models. M3258 leads to a significant and prolonged suppression of tumor LMP7 activity and ubiquitinated protein turnover and the induction of apoptosis in